Corteva, Inc.

Q1 FY26 Earnings Call Analysis

Chemicals

Full Stock Analysis
fundraise: No informationcapex: Yesrevenue: Category 3margin: Category 3orderbook: Yes
💰

fundraise

Any current/future new fundraising through debt or equity?

- No explicit mention of new fundraising through debt or equity in the provided transcript. - The company aims for both new businesses post-separation to maintain investment-grade credit profiles. - Board approved a $1.5 billion discretionary contribution to the U.S. pension plan to help position both companies for long-term success; this was funded from existing resources. - Capital structures for the two separated companies are being finalized, targeting investment-grade leverage levels. - No specific plans announced for issuing new debt or equity; focus is on strong balance sheets and credit metrics. - Share repurchase plan remains in place with approximately $500 million planned in the first half of the year. - Overall, current strategy emphasizes prudent capital allocation rather than raising new funds.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Expansion of biofuel crop development program globally with multiple partners. - Growing sustainable aviation fuel crop acreage: ~100,000 acres harvested in the southern U.S. last fall, expanding to over 400,000 acres next year. - Launching 50-50 JV with BP in Latin America to expand mustard crops, and starting canola and sunflower, with material planting expected in 2027. - Investment in proprietary next-gen aboveground and belowground traits for Vylor (formerly Corteva Seed & Genetics), expected around 2030-2031. - Continuing development and commercialization of at least 7 new active ingredients and biological products in Crop Protection over the next decade. - $1.5 billion discretionary contribution to U.S. pension plan supporting capital structure setup for both standalone companies post spin-off. - Strategic spend related to separation and setting up management and operational structures for new entities, including filing Form 10 and public listing preparations.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Next-gen aboveground products launching in North America by 2030; Latin America will have both above and below ground products by 2030-2031. - Pipeline includes at least 7 new active ingredients expected over the next decade. - New products projected to push $2 billion in revenue this year, with growth continuing. - Key future blockbusters include Avisa in Latin America, plus upcoming biologicals enhancing farm gate value. - Crop Protection volume growth expected mainly from Latin America in the second half of the year, driven by more acres planted and expanding biological portfolio. - Seed volumes up 6% in Q1 with strong early-season deliveries; price mix improving low to mid-single digits in second half. - Crop Protection volumes up 6% with new products and spinosyn driving double-digit growth. - Biofuel crop program expanding acreage significantly next few years, supporting long-term growth. - Overall, moderate organic growth expected with Crop Protection industry projected to grow low single digits in 2026.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Full year 2026 guidance reaffirmed: - Operating EBITDA expected between $4.0B to $4.2B - Operating EBITDA margin forecasted at 22% to 23% - Operating EPS projected in the range of $3.45 to $3.70, representing ~7% growth at midpoint - Strong Q1 2026 performance with 21% increase in EBITDA and 240 basis points margin expansion - Continued organic growth supported by price mix, volume gains, and cost savings - Expect modest industry growth in crop protection low single digits in 2026 with positive signs into 2027 - New products pipeline expected to drive growth, including 7 new active ingredients and biologicals in crop protection - Seed business becoming royalty positive this year, supported by $1B+ incremental revenue from out-licensing and hybrid wheat program - Productivity initiatives and cost discipline contributing to margin expansion and free cash flow conversion in line with midterm targets
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- The order book currently reflects expectations of increased corn acreage in the U.S., indicating strong demand (Page 8). - Latin America is a key driver for second-half volume growth, with more acres planted and growing demand for biologicals such as Nutricia and Blue (Page 11). - Crop Protection volumes forecast to grow from single digits in the first half to high single digits in the second half, primarily driven by Latin America (Page 11). - Strong demand exists for corn and soybean technology, supported by Bayer agreement, contributing about $1 billion in royalty revenue growth over the next decade (Page 5). - Biologicals and new product launches expected to contribute meaningfully to order growth in the second half, especially in Latin America (Page 4).